Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
News from the FDA/CDC
FDA authorizes Pfizer antiviral pill for COVID-19
Publish date:
December 22, 2021
A version of this article first appeared on
WebMD.com
.
Pages
« first
1
2
Recommended Reading
Telemedicine helps SCD patients survive COVID, but more need access
MDedge Internal Medicine
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
MDedge Internal Medicine
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
MDedge Internal Medicine
COVID cases spike as questions remain about Omicron’s threat
MDedge Internal Medicine
Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
MDedge Internal Medicine
Axilla swelling after COVID booster puts focus on mammogram timing
MDedge Internal Medicine
COVID-19 and coping with superimposed traumas
MDedge Internal Medicine
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
MDedge Internal Medicine
Bamlanivimab’s effects in COVID-19 depend on antibodies
MDedge Internal Medicine
Convalescent plasma cuts COVID-19 hospitalizations in half: Study
MDedge Internal Medicine
COVID-19 Updates
All Specialties
